Thus, we developed LNA-modified nucleolin aptamers and LNA-modified EpCAM aptamers conjugated “Fe-bLf natural anticancer protein-loaded nanobullet nanocarriers,” which specifically target cancer cells and spare normal cells. This evidence concerns the gene NUCLEOLIN and cancer.